Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Ion generation using wetted porous material
Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors assoc
Phosphonate compounds
Tablet computer
Brushless motor drive apparatus and drive method
Apparatus and method for efficient transmission of acknowledgements
  Randomly Featured Patents
Isoelectronic surfactant induced sublattice disordering in optoelectronic devices
Lithium battery electrode frame
System and method for operating a barrier with a timer
Imaging parameter recording apparatus, imaging method and editing system
Method and apparatus for compensating local oscillator frequency error through environmental control
Reversibly releasable latching apparatus
Utensil hand guard
Separation of organic compounds by adsorption processes
Integrated airbag closing and inflator mounting members for inflatable airbag assemblies
Image forming apparatus